Executive Director, Custom Intelligence & Analytics
23+ years of experience
Duncan has over 20 years of pharmaceutical industry experience and is currently Director of Pharma’s Custom Intelligence & Analytics team which focuses on supporting pharma, biotech, and life science clients to make informed decisions across the clinical-regulatory-commercial continuum.
Previously worked for a global market research firm where he was responsible for all syndicated disease analysis. Prior to that spent nearly a decade at Datamonitor Healthcare where he worked in company analysis, disease analysis, and the healthcare consulting team. Duncan has also held various roles at several pharma companies focused on non-clinical and clinical R&D, medical affairs, and sales/marketing.
A published authority on biosimilars, COVID-19 and lifecycle management, having authored whitepapers, articles and book chapters on these areas, including two chapters in Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand (Wiley, 2012).
Duncan holds a BSc(Hons) in Biochemistry from the University of Surrey and a PhD in Microbiology from the University of Kent.
19 Nov 2021